T Cell Expansion in PBS-Mini Using CellGenix Reagents
Introduction
Cell and gene therapies continue to be the fastestgrowing area of therapeutics, with several new
therapies available to patients and hundreds more
in development. Sustaining such innovation requires biopharma companies to solve many operational challenges, particularly in manufacturing
and scaling up therapies. Cell and gene therapies
typically require a substantial amount of cells per
dose, which means that bioreactor-based expansion of therapeutically active cells is key.
Download Now
